TY  - JOUR
AU  - Martín-Montañez, E
AU  - Pavia, J
AU  - Valverde, N
AU  - Boraldi, F
AU  - Lara, E
AU  - Oliver, B
AU  - Hurtado-Guerrero, I
AU  - Fernandez, O
AU  - Garcia-Fernandez, M
PY  - 2019
DO  - 10.1016/j.freeradbiomed.2019.04.022
UR  - http://hdl.handle.net/10668/13889
T2  - Free radical biology & medicine
AB  - Fingolimod is one of the few oral drugs available for the treatment of multiple sclerosis (MS), a chronic, inflammatory, demyelinating and neurodegenerative disease. The mechanism of action proposed for this drug is based in the phosphorylation of the...
LA  - en
KW  - Antioxidant
KW  - Fingolimod
KW  - Fingolimod phosphate
KW  - Mitochondria
KW  - Neuroprotection
KW  - Oxidative stress
KW  - Animals
KW  - Antioxidants
KW  - Cell Death
KW  - Cell Line
KW  - Dopaminergic Neurons
KW  - Fingolimod Hydrochloride
KW  - Humans
KW  - Lysophospholipids
KW  - Membrane Potential, Mitochondrial
KW  - Mice
KW  - Mitochondria
KW  - Molecular Mimicry
KW  - Multiple Sclerosis
KW  - Neuroprotection
KW  - Oxidative Stress
KW  - Oxygen Consumption
KW  - Phosphates
KW  - Reactive Oxygen Species
KW  - Sphingosine
KW  - Sphingosine-1-Phosphate Receptors
KW  - Vitamin K 3
TI  - The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.
TY  - research article
VL  - 137
ER  -